Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Calls For More Tier 4 Restrictions As Hospitals Strain Under Covid

Tue, 29th Dec 2020 15:39

(Alliance News) - Pressure is growing for the expansion of the toughest coronavirus restrictions in the face of increasing strain on hospitals in England where the number of patients has surpassed the April peak of the first wave.

Health Secretary Matt Hancock is due to announce any changes to tier areas in a statement to the Commons on Wednesday.

An expert adviser to the government said national coronavirus restrictions are needed to prevent a "catastrophe" amid rising infections, and the head of an organisation representing health trusts said "as much of the country as possible" should go into the harshest Tier 4.

The debate over the reopening of schools after the Christmas break is also continuing, with scientists and school leaders suggesting a delay might be needed amid rising cases.

The government said it is "still planning for a staggered opening of schools" after Christmas but is keeping the approach under constant review,

Professor Andrew Hayward, of the government's New & Emerging Respiratory Virus Threats Advisory Group said he thinks schools will have to return "maybe a little bit later" and reopening would mean "we're going to have to have increased, strict restrictions in other areas of society to pay for that".

Fellow Nervtag member Neil Ferguson said there had been a "balancing act" since lockdown was initially eased to try to keep control of the virus while maintaining "some semblance of normal society" but that the new variant had made it more difficult.

He told BBC Radio 4's World At One programme: "Clearly nobody wants to keep schools shut. But if that's the only alternative to having exponentially growing numbers of hospitalisations, that may be required at least for a period."

Geoff Barton, general secretary of the Association of School & College Leaders, welcomed the government's plans for soldiers to offer remote support for testing in schools, but warned it is unlikely to be enough.

Hayward, professor of infectious diseases epidemiology at University College London, said widespread Tier 4 restrictions – or even higher – are likely to be needed as the country moves towards "near-lockdown".

He told BBC Radio 4's Today programme: "I think we are entering a very dangerous new phase of the pandemic and we're going to need decisive, early, national action to prevent a catastrophe in January and February."

Asked whether a national Tier 4 lockdown should be brought in, NHS Providers deputy chief executive Saffron Cordery told BBC Radio Five Live: "I think we need to see, yes, as much of the country as possible in Tier 4."

She said some trusts are reporting up to three times the number of Covid-19 patients as at the peak of the first wave.

NHS England Chief Executive Simon Stevens has warned that doctors and nurses are "back in the eye of the storm".

Figures from NHS England show there were 20,426 patients in NHS hospitals in England at 0800 GMT on Monday, compared with 18,974 on April 12.

Stevens said: "Many of us have lost family, friends, colleagues and – at a time of year when we would normally be celebrating – a lot of people are understandably feeling anxious, frustrated and tired.

"And now, again, we are back in the eye of the storm with a second wave of coronavirus sweeping Europe and, indeed, this country."

Stevens said there is a "chink of hope" in the various Covid-19 vaccines, with the Oxford/AstraZeneca PLC jab expected to be approved imminently by the Medicines & Healthcare products Regulatory Agency, according to reports.

On Tuesday, 90-year-old grandmother Margaret Keenan, who became the first person in the world to receive the Pfizer Inc vaccine earlier this month following its clinical approval, was given her second dose at Coventry's University Hospital.

The current vaccination target will have to be doubled to two million jabs a week to avoid a third wave of the virus, according to a projection from a London School of Hygiene & Tropical Medicine paper reported by the Telegraph.

Trusts in England were told in a letter just before Christmas to begin planning for the use of Nightingale hospitals, although concerns have been raised around staffing the sites.

One senior doctor said some trusts in London and the South East are considering the option of setting up tents outside hospitals to triage patients.

Emergency medicine consultant Simon Walsh said staff are working in "major incident mode" and called on the government to set out a "coherent plan" to get through the coming weeks.

Paramedics in London are receiving support from other ambulance services in the South as they receive up to 8,000 emergency 999 calls each day.

South Central Ambulance Service said it is "pre-warning" the military and fire service that paramedics may need help after an average increase of 10% in 999 calls over the Christmas period and a threefold rise in 111 calls, along with a 60%-70% increase in absence rates with staff symptomatic or self-isolating.

The government said a further 357 people had died within 28 days of testing positive for Covid-19 as of Monday, taking the UK total to 71,109.

The number of further lab-confirmed cases recorded in a single day in the UK also hit a new high of 41,385 at 9am on Monday, rising above 40,000 for the first time, according to Government figures.

The true number is likely to be higher because figures do not include information from Scotland and Northern Ireland, which did not report data between December 24 and 28.

It is not possible to make direct comparisons with the level of infection during the first wave of the virus, because mass testing was only introduced in the UK in May, but it has been estimated there may have been as many 100,000 cases a day at the peak in late March and early April.

More than six million people in east and south-east England went into the highest level of restrictions on Saturday, meaning 24 million – 43% of the population – are now affected.

Lockdown measures are also in place across the other three home nations, after mainland Scotland entered Level 4 restrictions from Saturday for three weeks, and a similar stay-at-home order is in place in Wales.

Northern Ireland has also entered a new six-week lockdown, and the first-week measures are the toughest yet, with a form of curfew in operation from 8pm, shops closed from that time and all indoor and outdoor gatherings prohibited until 6am.

source: PA

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.